The results showed that carvacrol significantly improved weight loss in mice with LPS-induced sepsis; ameliorated pathological damage to the liver, lungs, and heart; and attenuated the inflammatory response by inhibiting LPS-induced production of the inflammatory cytokine interleukin-6 (IL-6) in vivo and in vitro. Here, IL6 is linked to Sepsis.